FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileSANUWAVE Health, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
SNWV
SANUWAVE Health, Inc. Stock AnalysisComprehensive stock analysis for SANUWAVE Health, Inc. (SNWV) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisSNWV
SNWV
SANUWAVE Health, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
SNWV
  1. Home
  2. Stocks
  3. SANUWAVE Health, Inc.

SANUWAVE Health, Inc.

🇺🇸SNWV•NASDAQ

SANUWAVE Health, Inc.

🇺🇸SNWV•NASDAQ
Market cap
$14.71M
Sentiment

Your view on SNWV

Mkt Cap
$14.71M
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About SANUWAVE Health, Inc.

Industry
Medical - Devices
Sector
Healthcare
CEO
Morgan C. Frank
Headquarters
3360 Martin Farm Road, Suwanee, GA, US
Industry
Medical - Devices
Sector
Healthcare
CEO
Morgan C. Frank
Headquarters
3360 Martin Farm Road, Suwanee, GA, US
Description

SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally.

Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers.

Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration.

The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions.

In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures.

The company was founded in 2005 and is headquartered in Suwanee, Georgia.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for SANUWAVE Health, Inc. from FRC's valuation model, read against the market price. SNWV last traded at $1.71, 5.5× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for SANUWAVE Health, Inc.. Starting points for SANUWAVE Health, Inc.: P/E 5.5, EPS $0.30, beta 1.48 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for SANUWAVE Health, Inc.. SANUWAVE Health, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for SANUWAVE Health, Inc.. Trailing twelve-month EPS for SANUWAVE Health, Inc. stands at $0.30. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$54.00

average of analysts' targets

 

$54.00

Low $53.00

Median $54.00

High $55.00

 

Analyst Ratings

Buy2 ratings
  • Strong Buy0
  • Buy2
  • Hold0
  • Sell0
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$0.07$0.29-$0.08$0.37
Low estimate$0.07$0.29-$0.08$0.37
High estimate$0.07$0.29-$0.08$0.37
No. of analysts1111
Year-ago EPS$0.031-$0.17$0.411—
Growth—+271.2%——

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$16.50M$8.10M$51.35M$64.50M
Low estimate$16.50M$8.10M$51.35M$64.50M
High estimate$16.50M$8.10M$51.35M$64.50M
No. of analysts1111
Year-ago revenue$13.09M$9.62M$44.05M—
Growth+26.0%-15.8%+16.6%—
Recent analyst actions5 rating and price-target changes, latest Mar 30, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for SANUWAVE Health, Inc.. SANUWAVE Health, Inc. has reported as a listed company since 2009. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold SNWV19 companies · 5 funds
Compare SNWV with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • FHTXFoghorn Therapeutics Inc.Biotechnology$107M
  • HSDTSolana CompanyAsset Management$95M
  • IMRXImmuneering CorporationBiotechnology$227M
  • INGNInogen, Inc.Medical - Devices$145M
  • MASS908 Devices Inc.Medical - Specialties$396M
  • NNOXNano-X Imaging Ltd.Medical - Devices$21M
  • OMOutset Medical, Inc.Medical - Devices$57M
  • QTRXQuanterix CorporationMedical - Devices$98M

More Medical - Devices companies

  • NHNKYNihon Kohden CorporationOTC$3.7B
  • NMRDNemaura Medical Inc.OTC$404
  • NMTCNeuroOne Medical Technologies CorporationNASDAQ$7M
  • NPCENeuroPace, Inc.NASDAQ$283M
  • NSPRInspireMD, Inc.NASDAQ$32M
  • NSYSNortech Systems IncorporatedNASDAQ$33M
  • NUMDNu-Med Plus, Inc.OTC$1M
  • NUWENuwellis, Inc.NASDAQ$353,130
  • NVCRNovoCure LimitedNASDAQ$1.3B
  • NVNOenVVeno Medical CorporationNASDAQ$4M
  • NWCINewCardio, Inc.OTC$3,315

ETFs holding SANUWAVE Health, Inc.

% of the fund

  • VTIVanguard Total Stock Market ETF$689.2B in assets0.00%
  • VXFVanguard Extended Market ETF$30.2B in assets0.00%
  • QQQSInvesco NASDAQ Future Gen 200 ETF$20M in assets0.22%
  • IWCiShares Micro-Cap ETF$1.2B in assets0.00%
  • VUN.TOVanguard U.S. Total Market Index ETF$20.1B in assets0.00%

Largest holders first, then the funds most concentrated in SNWV.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold SANUWAVE Health, Inc., and how their positions are changing. At a $14.7M market value, institutional positions materially move SANUWAVE Health, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by SANUWAVE Health, Inc. executives and directors. Shares of SANUWAVE Health, Inc. have traded between $18.50 and $46.59 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for SANUWAVE Health, Inc.. Coverage tracks SANUWAVE Health, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of SANUWAVE Health, Inc.

SNWV Analysis
Fair
Past1
Growth1
Health2
Profit5
Value5

News

Latest Market News